Jiangsu Kanion Pharmaceutical Co Ltd (600557) — Net Asset Momentum
Jiangsu Kanion Pharmaceutical Co Ltd (600557) recorded a net asset momentum of -12.6% as of December 2024, with net assets of CN¥4.71 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See how many days can Jiangsu Kanion Pharmaceutical Co Ltd fund operations to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Jiangsu Kanion Pharmaceutical Co Ltd Net Asset Momentum (1999–2024)
This chart tracks Jiangsu Kanion Pharmaceutical Co Ltd's year-over-year net asset growth across 26 annual reporting periods from 1999 to 2024. The most recent momentum reading is -12.6%, with net assets of CN¥4.71 Billion CNY as of December 2024. Read debt load of Jiangsu Kanion Pharmaceutical Co Ltd for a breakdown of total debt and financial obligations.
Annual Net Asset History for Jiangsu Kanion Pharmaceutical Co Ltd (1999–2024)
The table below shows the complete annual net asset history for Jiangsu Kanion Pharmaceutical Co Ltd from 1999 to 2024, covering 26 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see Jiangsu Kanion Pharmaceutical Co Ltd (600557) total market value.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | CN¥4.71 Billion | CN¥6.91 Billion | CN¥2.20 Billion | ▼ -12.6% |
| 2023 | CN¥5.38 Billion | CN¥7.12 Billion | CN¥1.74 Billion | ▲ +9.1% |
| 2022 | CN¥4.93 Billion | CN¥6.80 Billion | CN¥1.86 Billion | ▲ +10.3% |
| 2021 | CN¥4.47 Billion | CN¥6.02 Billion | CN¥1.55 Billion | ▲ +3.4% |
| 2020 | CN¥4.33 Billion | CN¥6.12 Billion | CN¥1.79 Billion | ▲ +5.9% |
| 2019 | CN¥4.09 Billion | CN¥6.11 Billion | CN¥2.02 Billion | ▲ +5.0% |
| 2018 | CN¥3.89 Billion | CN¥5.60 Billion | CN¥1.71 Billion | ▲ +8.3% |
| 2017 | CN¥3.59 Billion | CN¥5.39 Billion | CN¥1.80 Billion | ▲ +12.1% |
| 2016 | CN¥3.21 Billion | CN¥4.73 Billion | CN¥1.52 Billion | ▲ +11.7% |
| 2015 | CN¥2.87 Billion | CN¥4.30 Billion | CN¥1.43 Billion | ▲ +12.3% |
| 2014 | CN¥2.56 Billion | CN¥4.15 Billion | CN¥1.60 Billion | ▲ +32.1% |
| 2013 | CN¥1.93 Billion | CN¥3.43 Billion | CN¥1.50 Billion | ▲ +17.2% |
| 2012 | CN¥1.65 Billion | CN¥3.12 Billion | CN¥1.47 Billion | ▲ +11.9% |
| 2011 | CN¥1.47 Billion | CN¥2.58 Billion | CN¥1.11 Billion | ▲ +18.5% |
| 2010 | CN¥1.24 Billion | CN¥1.99 Billion | CN¥743.19 Million | ▲ +15.4% |
| 2009 | CN¥1.08 Billion | CN¥1.45 Billion | CN¥367.23 Million | ▲ +12.9% |
| 2008 | CN¥954.72 Million | CN¥1.31 Billion | CN¥355.85 Million | ▲ +71.1% |
| 2007 | CN¥557.95 Million | CN¥1.03 Billion | CN¥473.81 Million | ▲ +13.2% |
| 2006 | CN¥492.91 Million | CN¥936.11 Million | CN¥443.19 Million | ▲ +7.6% |
| 2005 | CN¥457.89 Million | CN¥990.51 Million | CN¥532.62 Million | ▲ +10.6% |
| 2004 | CN¥414.10 Million | CN¥784.98 Million | CN¥370.88 Million | ▲ +10.5% |
| 2003 | CN¥374.88 Million | CN¥778.43 Million | CN¥403.56 Million | ▲ +12.4% |
| 2002 | CN¥333.38 Million | CN¥426.07 Million | CN¥92.69 Million | ▲ +351.1% |
| 2001 | CN¥73.91 Million | CN¥177.52 Million | CN¥103.61 Million | ▲ +29.7% |
| 2000 | CN¥57.01 Million | CN¥175.93 Million | CN¥118.92 Million | ▲ +37.2% |
| 1999 | CN¥41.54 Million | CN¥155.38 Million | CN¥113.84 Million | — |